Vista Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.52 | 3.47 | 2.68 |
| Operating Expense | 2.63 | 4.14 | 4.07 |
| Net Profit | -1.29 | -1.50 | -1.32 |
| Net Profit Margin | -84.87 | -43.23 | -49.25 |
| Earning Per Share | -0.22 | -0.79 | -0.07 |
| EBIDTA | -0.92 | -0.68 | -0.91 |
| Effective Tax Rate | TBA | -64.18 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.52 |
| Operating Expense | 2.63 |
| Net Profit | -1.29 |
| Net Profit Margin | -84.87 |
| Earning Per Share | -0.22 |
| EBIDTA | -0.92 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 10.07 | 10.29 | 1.00 |
| Operating Expenses Annual | 14.10 | 13.60 | 5.45 |
| Operating Profit Annual | -3.59 | -3.24 | -4.05 |
| Interest Annual | 0.96 | 1.22 | 1.21 |
| Depreciation | 0.74 | 0.72 | 0.62 |
| Net Profit Annual | -4.65 | -4.51 | -5.66 |
| Tax Annual | -0.64 | -0.67 | -0.21 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 10.07 |
| Operating Expenses Annual | 14.10 |
| Operating Profit Annual | -3.59 |
| Interest Annual | 0.96 |
| Depreciation | 0.74 |
| Net Profit Annual | -4.65 |
| Tax Annual | -0.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.09 | 0.20 | 0.07 |
| Cash Flow from Operations | -6.98 | -4.91 | -1.71 |
| Cash Flow from Investing | -0.44 | -0.79 | -1.27 |
| Cash Flow from Financing | 8.06 | 5.59 | 3.11 |
| Cash Flow at the End | 0.73 | 0.09 | 0.20 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | -6.98 |
| Cash Flow from Investing | -0.44 |
| Cash Flow from Financing | 8.06 |
| Cash Flow at the End | 0.73 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -35.55 | -31.29 | -392 |
| PBIT Margin (%) | -42.90 | -38.29 | -454 |
| PBT Margin (%) | 1.29 | -7.39 | -116 |
| Net PROFIT Margin (%) | -46.18 | -43.83 | -566 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -9.24 | -9.64 | -11.32 |
| Total Debt / Equity (X) | 0.18 | 0.23 | 0.31 |
| Asset Turnover Ratio (%) | 0.20 | 0.22 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -35.55 |
| PBIT Margin (%) | -42.90 |
| PBT Margin (%) | 1.29 |
| Net PROFIT Margin (%) | -46.18 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -9.24 |
| Total Debt / Equity (X) | 0.18 |
| Asset Turnover Ratio (%) | 0.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 18.70 | 19.32 | 19.74 |
| Total Current Assets Annual | 24.91 | 23.40 | 23.75 |
| Non Current Assets Annual | 35.38 | 34.58 | 32.28 |
| Total Shareholders Funds Annual | 45.42 | 40.46 | 36.71 |
| Total Assets Annual | 60.29 | 57.98 | 56.03 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 18.70 |
| Total Current Assets Annual | 24.91 |
| Non Current Assets Annual | 35.38 |
| Total Shareholders Funds Annual | 45.42 |
| Total Assets Annual | 60.29 |
No Data Availabe
